Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Cash from Financing Activities (2020 - 2025)

NeuroPace has reported Cash from Financing Activities over the past 6 years, most recently at $635000.0 for Q4 2025.

  • Quarterly results put Cash from Financing Activities at $635000.0 for Q4 2025, down 25.12% from a year ago — trailing twelve months through Dec 2025 was $19.6 million (up 352.97% YoY), and the annual figure for FY2025 was $19.6 million, up 352.97%.
  • Cash from Financing Activities for Q4 2025 was $635000.0 at NeuroPace, up from -$235000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for NPCE hit a ceiling of $103.2 million in Q2 2021 and a floor of -$1.9 million in Q2 2025.
  • Median Cash from Financing Activities over the past 5 years was $195000.0 (2023), compared with a mean of $7.1 million.
  • Biggest five-year swings in Cash from Financing Activities: crashed 25600.0% in 2023 and later soared 29216.67% in 2025.
  • NeuroPace's Cash from Financing Activities stood at $911000.0 in 2021, then plummeted by 115.15% to -$138000.0 in 2022, then soared by 6052.17% to $8.2 million in 2023, then crashed by 89.68% to $848000.0 in 2024, then dropped by 25.12% to $635000.0 in 2025.
  • The last three reported values for Cash from Financing Activities were $635000.0 (Q4 2025), -$235000.0 (Q3 2025), and -$1.9 million (Q2 2025) per Business Quant data.